Cargando…
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood volume, cardiac...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340112/ https://www.ncbi.nlm.nih.gov/pubmed/22563249 http://dx.doi.org/10.2147/DMSO.S30005 |